Stay updated on Durvalumab & Olaparib in Endometrial Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab & Olaparib in Endometrial Cancer Clinical Trial page.

Latest updates to the Durvalumab & Olaparib in Endometrial Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedA page revision update from v3.6.3 to v3.6.4 indicates a maintenance-level change to the page's versioning, with the underlying study information remaining the same.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check31 days agoChange DetectedThe revision tag was updated from v3.6.2 to v3.6.3. This appears to be a small deployment/build update and does not indicate changes to the page content or data presented.SummaryDifference0.0%

- Check38 days agoChange DetectedThe page now displays Revision: v3.6.2, replacing the previous Revision: v3.6.0. This indicates a newer release or update to the document.SummaryDifference0.0%

- Check52 days agoChange DetectedNew help sections were added (How to Read a Study Record, Common Questions, How to Join a Study), the Intervention/Treatment label formatting was updated (Intervention/Treatment added, Intervention / Treatment removed), and the page revision updated to v3.6.0.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page now reports 201 locations for the study, down from 202, following the removal of Erlangen, Germany. This change updates the live listing to reflect the current sites where the study is conducted.SummaryDifference0.1%

- Check81 days agoChange DetectedENGOT is added as a collaborator for the study, and the associated investigator list is updated accordingly. Publication references are updated to include the Phase III DUO-E article in J Clin Oncol and the Erratum, along with a new revision version (v3.5.4).SummaryDifference0.1%

Stay in the know with updates to Durvalumab & Olaparib in Endometrial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab & Olaparib in Endometrial Cancer Clinical Trial page.